OneMedNet Corp Dossier
|
SectorHealth Care IndustryHealth Care Technology Beta (adjusted)1.14 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $5.50Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $32M Enterprise Value $31.8M Shares Outstanding 64.2M diluted All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary OneMedNet Corp (NASDAQ: ONMD) is a highly specialized healthcare technology company focused on curating regulatory-grade Imaging Real-World Data (iRWD) for life sciences, medical device, and AI developers. While the company has demonstrated impressive operational momentum—surpassing 90 million patient journeys across a network of over 2,300 healthcare partner sites and securing over $3 million in new bookings in the first half of 2026—it faces severe financial and liquidity constraints. With a cash balance of just $233,000 as of March 31, 2026, a substantial accumulated deficit, and an active Nasdaq minimum bid price deficiency notice, the company represents a high-risk, high-reward micro-cap play. A 'Hold' recommendation is advised until the company secures stable long-term financing and demonstrates a clear path to profitability. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Our research · scenarios, merits, risks, and invalidation triggersResearch as of 19 Jun 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario The company fails to raise sufficient capital, leading to severe operational disruption or insolvency. Additionally, failure to regain compliance with Nasdaq's $1.00 minimum bid price requirement by October 12, 2026, results in delisting to the OTC markets, severely limiting liquidity and depressing the stock price. Base CaseCentral scenario The company successfully leverages its partnership with Palantir Foundry to accelerate data delivery and convert its $3 million in YTD bookings into recognized revenue by Q3 2026. It manages to raise dilutive but necessary capital to sustain operations and executes a reverse stock split or experiences a price recovery to regain Nasdaq compliance. Bull CaseUpside scenario OneMedNet is successfully transitioning from project-based work to a high-margin, recurring subscription model powered by its Palantir Foundry-integrated iRWD platform. This shift is driving rapid commercial traction, as evidenced by securing over $3 million in new bookings in the first half of 2026 (surpassing full-year 2025 bookings of $2.79 million). With its network expanding to over 90 million patient journeys and 2,300 sites, the company is well-positioned to capture growing demand for regulatory-grade, multi-modal real-world data from life sciences and AI developers. Scenarios reflect our research view at the research date. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |